-
1
-
-
84870370352
-
-
World Health Organization. World Health Organization, Geneva, Switzerland
-
World Health Organization. 2012. Global tuberculosis report 2012. World Health Organization, Geneva, Switzerland.
-
(2012)
Global Tuberculosis Report 2012
-
-
-
3
-
-
84867614599
-
Linezolid for treatment of chronic extensively drug-resistant tuberculosis
-
Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, Via LE, Goldfeder LC, Kang E, Jin B, Park H, Kwak H, Kim H, Jeon H, Jeong I, Joh JS, Chen RY, Olivier KN, Shaw PA, Follmann D, Song SD, Lee J, Lee D, Kim CT, Dartois V, Park S, Cho S, Barry CE. 2012. Linezolid for treatment of chronic extensively drug-resistant tuberculosis. N. Engl. J. Med. 367:1508-1518.
-
(2012)
N. Engl. J. Med.
, vol.367
, pp. 1508-1518
-
-
Lee, M.1
Lee, J.2
Carroll, M.W.3
Choi, H.4
Min, S.5
Song, T.6
Via, L.E.7
Goldfeder, L.C.8
Kang, E.9
Jin, B.10
Park, H.11
Kwak, H.12
Kim, H.13
Jeon, H.14
Jeong, I.15
Joh, J.S.16
Chen, R.Y.17
Olivier, K.N.18
Shaw, P.A.19
Follmann, D.20
Song, S.D.21
Lee, J.22
Lee, D.23
Kim, C.T.24
Dartois, V.25
Park, S.26
Cho, S.27
Barry, C.E.28
more..
-
4
-
-
84863177484
-
Linezolid in the treatment of MDR-TB: A retrospective clinical study
-
Xu HB, Jiang RH, Li L, Xiao HP. 2012. Linezolid in the treatment of MDR-TB: a retrospective clinical study. Int. J. Tuberc. Lung Dis. 16:358-363.
-
(2012)
Int. J. Tuberc. Lung Dis.
, vol.16
, pp. 358-363
-
-
Xu, H.B.1
Jiang, R.H.2
Li, L.3
Xiao, H.P.4
-
6
-
-
0028890884
-
Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin
-
Conte JE, Jr, Golden JA, Duncan S, McKenna E, Zurlinden E. 1995. Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin. Antimicrob. Agents Chemother. 39:334-338.
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 334-338
-
-
Conte Jr., J.E.1
Golden, J.A.2
Duncan, S.3
McKenna, E.4
Zurlinden, E.5
-
7
-
-
0030956116
-
Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers
-
Rodvold KA, Gotfried MH, Danziger LH, Servi RJ. 1997. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrob. Agents Chemother. 41:1399-1402.
-
(1997)
Antimicrob. Agents Chemother.
, vol.41
, pp. 1399-1402
-
-
Rodvold, K.A.1
Gotfried, M.H.2
Danziger, L.H.3
Servi, R.J.4
-
8
-
-
0029018666
-
Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis
-
Cavalieri SJ, Biehle JR, Sanders WE, Jr. 1995. Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 39:1542-1545.
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 1542-1545
-
-
Cavalieri, S.J.1
Biehle, J.R.2
Sanders Jr., W.E.3
-
9
-
-
0026497536
-
Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses
-
Chu SY, Sennello LT, Bunnell ST, Varga LL, Wilson DS, Sonders RC. 1992. Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses. Antimicrob. Agents Chemother. 36:2447-2453.
-
(1992)
Antimicrob. Agents Chemother.
, vol.36
, pp. 2447-2453
-
-
Chu, S.Y.1
Sennello, L.T.2
Bunnell, S.T.3
Varga, L.L.4
Wilson, D.S.5
Sonders, R.C.6
-
10
-
-
77954467776
-
Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients
-
Alffenaar JW, van Altena R, Harmelink IM, Filguera P, Molenaar E, Wessels AM, van Soolingen D, Kosterink JG, Uges DR, van der Werf TS. 2010. Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients. Clin. Pharmacokinet. 49:559-565.
-
(2010)
Clin. Pharmacokinet.
, vol.49
, pp. 559-565
-
-
Alffenaar, J.W.1
Van Altena, R.2
Harmelink, I.M.3
Filguera, P.4
Molenaar, E.5
Wessels, A.M.6
Van Soolingen, D.7
Kosterink, J.G.8
Uges, D.R.9
Van Der Werf, T.S.10
-
11
-
-
78649639526
-
Clarithromycin significantly increases linezolid serum concentrations
-
Bolhuis MS, van Altena R, Uges DR, van der Werf TS, Kosterink JG, Alffenaar JW. 2010. Clarithromycin significantly increases linezolid serum concentrations. Antimicrob. Agents Chemother. 54:5418-5419.
-
(2010)
Antimicrob. Agents Chemother.
, vol.54
, pp. 5418-5419
-
-
Bolhuis, M.S.1
Van Altena, R.2
Uges, D.R.3
Van Der Werf, T.S.4
Kosterink, J.G.5
Alffenaar, J.W.6
-
12
-
-
84868030937
-
Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis
-
Vu DH, Bolhuis MS, Koster RA, Greijdanus B, de Lange WC, van Altena R, Brouwers JR, Uges DR, Alffenaar JW. 2012. Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis. Antimicrob. Agents Chemother. 56:5758-5763.
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 5758-5763
-
-
Vu, D.H.1
Bolhuis, M.S.2
Koster, R.A.3
Greijdanus, B.4
De Lange, W.C.5
Van Altena, R.6
Brouwers, J.R.7
Uges, D.R.8
Alffenaar, J.W.9
-
13
-
-
84864773767
-
A rapid and simple liquid chromatography-tandem mass spectrometry method for the determination of linezolid in human serum
-
Harmelink IM, Alffenaar JW, Wessels AM, Greijdanus B, Uges DR. 2008. A rapid and simple liquid chromatography-tandem mass spectrometry method for the determination of linezolid in human serum. EJHP Science 14:3-7.
-
(2008)
EJHP Science
, vol.14
, pp. 3-7
-
-
Harmelink, I.M.1
Alffenaar, J.W.2
Wessels, A.M.3
Greijdanus, B.4
Uges, D.R.5
-
14
-
-
66149091987
-
Simultaneous determination of clarithromycin, rifampicin and their main metabolites in human plasma by liquid chromatography-tandem mass spectrometry
-
de Velde F, Alffenaar JW, Wessels AM, Greijdanus B, Uges DR. 2009. Simultaneous determination of clarithromycin, rifampicin and their main metabolites in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 1771-1777.
-
(2009)
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.
, vol.877
, pp. 1771-1777
-
-
De Velde, F.1
Alffenaar, J.W.2
Wessels, A.M.3
Greijdanus, B.4
Uges, D.R.5
-
15
-
-
0036990101
-
Single-and multiple-dose pharmacokinetics of oral moxifloxacin and clarithromycin, and concentrations in serum, saliva and faeces
-
Burkhardt O, Borner K, Stass H, Beyer G, Allewelt M, Nord CE, Lode H. 2002. Single-and multiple-dose pharmacokinetics of oral moxifloxacin and clarithromycin, and concentrations in serum, saliva and faeces. Scand. J. Infect. Dis. 34:898-903.
-
(2002)
Scand. J. Infect. Dis.
, vol.34
, pp. 898-903
-
-
Burkhardt, O.1
Borner, K.2
Stass, H.3
Beyer, G.4
Allewelt, M.5
Nord, C.E.6
Lode, H.7
-
16
-
-
0027203475
-
Penetration of clarithromycin into human saliva
-
Wust J, Hardegger U. 1993. Penetration of clarithromycin into human saliva. Chemotherapy 39:293-296.
-
(1993)
Chemotherapy
, vol.39
, pp. 293-296
-
-
Wust, J.1
Hardegger, U.2
-
17
-
-
84880272515
-
-
Product information. Pfizer, New York, NY
-
Pfizer. 2005. Zyvoxid. Product information. Pfizer, New York, NY.
-
(2005)
Zyvoxid
-
-
Pfizer1
-
18
-
-
0027982022
-
Saliva versus blood sampling for therapeutic drug monitoring in children: Patient and parental preferences and an economic analysis
-
Gorodischer R, Burtin P, Hwang P, Levine M, Koren G. 1994. Saliva versus blood sampling for therapeutic drug monitoring in children: patient and parental preferences and an economic analysis. Ther. Drug Monit. 16:437-443.
-
(1994)
Ther. Drug Monit.
, vol.16
, pp. 437-443
-
-
Gorodischer, R.1
Burtin, P.2
Hwang, P.3
Levine, M.4
Koren, G.5
|